Allogeneic peripheral blood stem cell transplant [PBSCT] using anti-il2 receptor antibody daclizumab for the prevention of acute graft versus host disease in steroid refractory diamond blackfan anaemia: a case report
JPMA-Journal of Pakistan Medical Association. 2005; 55 (10): 454-455
Dans Anglais
| IMEMR
| ID: emr-166397
ABSTRACT
The case report of a 2 year old boy with steroid refractory DBA, treated with allogeneic PBSCT from an HLA matched sibling is presented. Anti-IL2 receptor antibody Daclizumab was used as a prophylaxis for graft versus host disease [GvHD]. Complete recovery without any evidence of GvHD ensued
Recherche sur Google
Indice:
Méditerranée orientale
langue:
Anglais
Texte intégral:
J. Pak. Med. Assoc.
Année:
2005
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS